They voted to APPROVE!!!! HERE IT IS.. (1 Rating) 6 minutes ago SILVER SPRING, Md., April 24 (Reuters) - A U.S. advisory panel unanimously recommended approval on Tuesday of a novel Pfizer Inc. (PFE.N: Quote, Profile , Research) AIDS drug called maraviroc that may offer a new option for patients resistant to older medicines.
The Food and Drug Administration will make the final decision. The agency usually follows panel recommendations